DI
SLS icon

DAGCO Inc’s SELLAS Life Sciences SLS Stock Holding History

DAGCO Inc’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.5M Buy
1,336,449
+104,016
+8% +$1.3M 2.85% 11
2026
Q2 		$18.2M Buy
1,232,433
+203,653
+20% +$1.41M 3.36% 10
2026
Q1 		$4.35M Buy
1,028,780
+451,240
+78% +$2.02M 0.94% 23
2025
Q4 		$2.18M Buy
+577,540
New +$1.12M 0.5% 34

Other funds holding SLS

Everhart Financial Group
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Fulcrum Wealth Advisors
Fulcrum Wealth Advisors Bellevue, Washington $144M AUM 21.17% 1-Year Est. Return
Vision Financial Markets
Vision Financial Markets Stamford, Connecticut $131M AUM 8.71% 1-Year Est. Return
Accurate Wealth Management
Accurate Wealth Management Wesley Chapel, Florida $1.16B AUM 24.67% 1-Year Est. Return
Instrumental Wealth
Instrumental Wealth Tampa, Florida $206M AUM 16.83% 1-Year Est. Return
NAMP
NorthStar Asset Management (Pennsylvania) Blue Bell, Pennsylvania $553M AUM 22.48% 1-Year Est. Return
Axxcess Wealth Management
Axxcess Wealth Management Carlsbad, California $2.44B AUM 16.42% 1-Year Est. Return
SJS Investment Consulting
SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return
Visionary Horizons
Visionary Horizons Knoxville, Tennessee $251M AUM 14.92% 1-Year Est. Return

DAGCO Inc's SLS Position: Q3 2026 in Review

DAGCO Inc increased its SELLAS Life Sciences (SLS) stake by 8.4% in Q3 2026, buying an estimated $1.3M and bringing the position to 1,336,449 shares worth $16.5M. The position accounts for 2.85% of the portfolio, ranked #11.

DAGCO Inc first reported a position in SLS in Q4 2025 and has held it in 4 quarters since. The position peaked at $18.2M in Q2 2026. 41 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • DAGCO Inc held 1,336,449 shares of SELLAS Life Sciences worth $16.5M as of Q3 2026.
  • DAGCO Inc bought 104,016 SELLAS Life Sciences shares in Q3 2026, an estimated $1.3M.
  • SELLAS Life Sciences made up 2.85% of DAGCO Inc's portfolio in Q3 2026, its #11 holding.
  • DAGCO Inc first reported a position in SELLAS Life Sciences in Q4 2025 and has held it in 4 quarters since.
  • DAGCO Inc's SELLAS Life Sciences position peaked at $18.2M in Q2 2026.
  • 41 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on DAGCO Inc's 13F filing for Q3 2026, filed 20 Oct 2026.